Balaxi Pharmaceuticals Ltd vs Unichem Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 22.85 as of 12 Jun 15:30 . The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 13.8 on March 2021 to 14.1 on March 2025 . This represents a CAGR of 0.43% over 5 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 35.5 on March 2025 . This represents a CAGR of -10.95% over 5 years The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 524.5 crore on March 2021 to ₹ 352.89 crore on March 2025 . This represents a CAGR of -7.62% over 5 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 2177 crore on March 2021 to ₹ 4877 crore on March 2025 . This represents a CAGR of 17.50% over 5 years The revenue of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 73.63 crore as compare to the Dec '25 revenue of ₹ 72.64 crore. This represent the growth of 1.36% The revenue of Unichem Laboratories Ltd for the Mar '26 is ₹ 598.59 crore as compare to the Dec '25 revenue of ₹ 808.49 crore. This represent the decline of -25.96% The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '26 is ₹ 3.04 crore as compare to the Dec '25 ebitda of ₹ 3.19 crore. This represent the decline of -4.7% The ebitda of Unichem Laboratories Ltd for the Mar '26 is ₹ 58.79 crore as compare to the Dec '25 ebitda of ₹ 332.1 crore. This represent the decline of -82.3% The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ 6.48 crore to ₹ 0.61 crore over 8 quarters. This represents a CAGR of -69.32% The net profit of Unichem Laboratories Ltd changed from ₹ 2.07 crore to ₹ 10.91 crore over 8 quarters. This represents a CAGR of 129.58% The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from 52.07 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Balaxi Pharmaceuticals Ltd

Balaxi Pharmaceuticals Limited was initially incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017 and further changed to Balaxi Pharmaceuticals Limited in 2021.
Initially, the Company was incorporated with the object of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Unichem Laboratories Ltd

Unichem Laboratories Limited manufactures active pharmaceutical ingredients.
The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
The Baddi plant was approved by UK MHRA and MCC (South Africa).
The company received ISO 9001:2000 for all their plants and corporate office.

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Unichem Laboratories Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 126 Cr while Market cap of Unichem Laboratories Ltd is 3,140 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd?

As of June 15, 2026, the Balaxi Pharmaceuticals Ltd stock price is INR ₹22.85. On the other hand, Unichem Laboratories Ltd stock price is INR ₹446.1.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.